tirzepatide higher dose trial Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Higher Doses= More Weight Loss?

Although clinical trials of Wegovy did not support an increased risk of suicidal behavior, suicidal ideation or other psychiatric adverse events, clinical trials of other weight management drugs have reported suicidal behavior and ideation, a spokesperson for the Food and Drug Administration said Monday

interestingly, GLP-1 users lost weight, while control groups gained

Study Design: This was a phase 3b, multicenter, parallel-arm, open-label, randomized, controlled clinical trial that was conducted over a 72 week period in the United States and Puerto Rico

Hormonal shifts, changes in muscle mass, sleep disruption, and digestive changes can influence how the body responds to a given dose